1. Home
  2. BLFY vs TXMD Comparison

BLFY vs TXMD Comparison

Compare BLFY & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFY
  • TXMD
  • Stock Information
  • Founded
  • BLFY 1939
  • TXMD 2008
  • Country
  • BLFY United States
  • TXMD United States
  • Employees
  • BLFY N/A
  • TXMD N/A
  • Industry
  • BLFY Commercial Banks
  • TXMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLFY Finance
  • TXMD Health Care
  • Exchange
  • BLFY Nasdaq
  • TXMD Nasdaq
  • Market Cap
  • BLFY 191.7M
  • TXMD 12.7M
  • IPO Year
  • BLFY N/A
  • TXMD N/A
  • Fundamental
  • Price
  • BLFY $9.20
  • TXMD $1.08
  • Analyst Decision
  • BLFY Hold
  • TXMD
  • Analyst Count
  • BLFY 1
  • TXMD 0
  • Target Price
  • BLFY $10.00
  • TXMD N/A
  • AVG Volume (30 Days)
  • BLFY 33.6K
  • TXMD 16.8K
  • Earning Date
  • BLFY 10-22-2025
  • TXMD 11-11-2025
  • Dividend Yield
  • BLFY N/A
  • TXMD N/A
  • EPS Growth
  • BLFY N/A
  • TXMD N/A
  • EPS
  • BLFY N/A
  • TXMD N/A
  • Revenue
  • BLFY $41,939,000.00
  • TXMD $2,559,000.00
  • Revenue This Year
  • BLFY $20.35
  • TXMD $427.09
  • Revenue Next Year
  • BLFY $19.30
  • TXMD N/A
  • P/E Ratio
  • BLFY N/A
  • TXMD N/A
  • Revenue Growth
  • BLFY 0.22
  • TXMD 156.93
  • 52 Week Low
  • BLFY $8.24
  • TXMD $0.70
  • 52 Week High
  • BLFY $11.38
  • TXMD $2.44
  • Technical
  • Relative Strength Index (RSI)
  • BLFY 49.50
  • TXMD 44.11
  • Support Level
  • BLFY $8.98
  • TXMD $1.06
  • Resistance Level
  • BLFY $9.59
  • TXMD $1.14
  • Average True Range (ATR)
  • BLFY 0.28
  • TXMD 0.05
  • MACD
  • BLFY -0.02
  • TXMD 0.00
  • Stochastic Oscillator
  • BLFY 33.85
  • TXMD 15.79

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: